Multiple Sclerosis Clinical Trial
Official title:
Validity and Reliability of Lower Extremity Position Test in Patients With Multiple Sclerosis
Verified date | November 2023 |
Source | Pamukkale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Sensory disorders are one of the most important problems in individuals with MS, and these disorders are among the first symptoms of MS. Loss of sense of proprioception is particularly common in patients with MS. Studies show that assessment methods for the quantitative measurement of sensory disorders are lacking. Especially in the clinic, there is no evaluation method that evaluates the sense of proprioception. Therefore, the aim of this study perform the validity and reliability study of the lower extremity position test to evaluate proprioception sense in individuals with MS.
Status | Active, not recruiting |
Enrollment | 90 |
Est. completion date | July 2024 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 65 Years |
Eligibility | Inclusion Criteria: - 20-65 years old - EDSS score between 0-5 - Person who has not had an attack in the last 1 month or who is not in the attack period - Person without systemic disease such as hypertension, heart disease, Diabetes Mellitus, hyperlipidemia, malignancy - Person who has not undergone surgery that restricts balance function in the lower extremity. - Person without hip, knee and ankle contracture - Person who does not have additional neurological disease - Person who does not use vestibulosupressants or drugs that may cause neuropathy and does not have a history of alcohol use - To have full cooperation and adaptation to the work - Individuals who agree to receive treatment will be included in the study. Exclusion Criteria: - Being younger than 20 years old and over 65 years old - Being in the attack period - Hip, knee or ankle contracture - Being greater than EDSS 5 - Having systemic diseases such as hypertension, heart disease, Diabetes Mellitus, hyperlipidemia, malignancy - Having an additional neurological disease - Having a vestibulospressant or drug or alcohol use habit that causes neuropathy - Not cooperating and adapting to the work |
Country | Name | City | State |
---|---|---|---|
Turkey | Romatem Bursa Fizik Tedavi ve Rehabilitasyon Hastanesi | Bursa |
Lead Sponsor | Collaborator |
---|---|
Pamukkale University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sensorial Assessment-1 | Lower Extremity Position test | through study completion, an average of 1 year | |
Primary | Sensorial Assessment-2 | Kinesthesia (Inclinometer) | through study completion, an average of 1 year | |
Primary | Balance Assessment-1 | Static Balance via single leg stance | through study completion, an average of 1 year | |
Primary | Balance Assessment-2 | Dynamic Balance via time up and go | through study completion, an average of 1 year | |
Primary | Walking Speed Assessment | The 10 meter walk test | through study completion, an average of 1 year | |
Secondary | Demographic Assessment | Demographic form | through study completion, an average of 1 year | |
Secondary | Expanded Disability Status Scale (EDSS) | Ranges from 0 to 10 in 0.5 unit increments that represent higher levels of disability. | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |